GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang East-Asia Pharmaceutical Co Ltd (SHSE:605177) » Definitions » Common Stock

Zhejiang East-Asia Pharmaceutical Co (SHSE:605177) Common Stock : ¥115 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Zhejiang East-Asia Pharmaceutical Co Common Stock?

Zhejiang East-Asia Pharmaceutical Co's quarterly common stock increased from Mar. 2024 (¥114 Mil) to Jun. 2024 (¥115 Mil) and increased from Jun. 2024 (¥115 Mil) to Sep. 2024 (¥115 Mil).

Zhejiang East-Asia Pharmaceutical Co's annual common stock stayed the same from Dec. 2021 (¥114 Mil) to Dec. 2022 (¥114 Mil) and stayed the same from Dec. 2022 (¥114 Mil) to Dec. 2023 (¥114 Mil).


Zhejiang East-Asia Pharmaceutical Co Common Stock Historical Data

The historical data trend for Zhejiang East-Asia Pharmaceutical Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang East-Asia Pharmaceutical Co Common Stock Chart

Zhejiang East-Asia Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial 85.20 113.60 113.60 113.60 113.60

Zhejiang East-Asia Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 113.60 113.60 113.60 114.75 114.75

Zhejiang East-Asia Pharmaceutical Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Zhejiang East-Asia Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 118, Laodong North Road, 23rd Floor, Chamber of Commerce Building, Huangyan District, Zhejiang Province, Taizhou, CHN
Zhejiang East-Asia Pharmaceutical Co Ltd is mainly engaged in the production of bulk pharmaceutical chemicals, tablets, granules and capsules. The company's main products are: Ofloxacin, levofloxacin, loratadine hydrochloride, levofloxacin hydrochloride, trimebutine maleate, ketoconazole, terbinafine hydrochloride, piperazine, ticlazole and so on.

Zhejiang East-Asia Pharmaceutical Co Headlines

No Headlines